SEC Form 4 · accession 0001683168-18-002823
Avid Bioservices, Inc. · CDMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel McComb
Director
Period of report
Sep 19, 2018
Accepted (ET)
Sep 21, 2018 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000704562
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Sep 19, 2018 | S | 25,733 | $6.4814 | D | 24,267 | D | |
| Common Stock, $0.001 par valueF2 | Sep 20, 2018 | S | 24,267 | $6.5727 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $6.45 to $6.575 per share. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F2This transaction was executed in multiple trades at prices ranging from $6.474 to $6.646 per share. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.